Galanin(1-15) reverses the impaired long-term memory effect of fluoxetine in the novel object recognition test. Role of 5-HT1A receptor in medial prefrontal cortex
Loading...
Files
Description: Abstract Congreso
Identifiers
Publication date
Reading date
Collaborators
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Share
Center
Keywords
Abstract
In this work, we have studied the effects of GAL(1-15) on FLX- mediated effects on the NOR and the OLM, two tasks where FLX treatment impaired long-term memories 24h post-training. Since the mPFC is a core region for the interaction between emotional processing and cognition with a high density of 5-HT1AR and GALR1 and GALR2, we have also analyzed the binding characteristics and mRNA levels of 5-HT1AR in the mPFC after GAL(1-15)-FLX administration in rats. A discrimination index (DI) was calculated as: DI=(N-F)/(N+F), and represent the difference in exploration time expressed as a proportion of the total time spent exploring the two objects. To analyze the binding characteristics and mRNA levels of 5-HT1AR, group of animals (n=6) were injected with FLX(10mg/kg) and GAL(1-15)(1nmol) alone or in combination and coronal sections of the mPFC were obtained to perform a quantitative autoradiography and in situ hybridization experiments In the NOR task, GAL(1-15)+FLX reversed the impairment memory effect induced by FLX(10mg/Kg) (p<0.05). This effect was blocked by the GALR2 antagonist M871. On the contrary, GAL(1-15) did not reverse the effect of FLX in the OLM task. In the autoradiographic experiments, GAL(1-15)+FLX increased the Kd (p<0.01) and the Bmax (p<0.05) values of the agonist radioligand [3H]-8-OH-DPAT compared with FLX in the mPFC. The coadministration also increased the 5-HT1AR mRNA levels (p<0.01) compared with the FLX group. Our results describe an interactions between GAL(1-15) and FLX in the mPFC involving interactions at the 5-HT1AR receptor level with implications also at functional level. The GALR1-GALR2-5-HT1A heteroreceptor could be used to reverse some of the adverse effects of FLX on memory processes.













